Global Urinary Incontinence Care Products Market
Market Size in USD Billion
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 11.99 Billion |
Market Size (Forecast Year) |
USD 21.38 Billion |
CAGR |
|
Major Markets Players |
Global Urinary Incontinence Care Products Market, By Product Type (Urine Bags, Urinary Catheter, Others), Sales Channel (Institutional Sales, Modern Trade, Departmental Stores, Convenience Stores, Specialty Stores, Online Retailers, Drug Stores, Other Sales Channels), Raw Material (Latex, Plastic, Cotton Fabrics, Super Absorbents), Consumer Orientation (Male, Female), Functionality (Disposable, Reusable), Product Claim (Organic, Natural), Application (Urine Incontinence, Faecal Incontinence, Dual Incontinence) Incontinence Type (Stress, Urge, Mixed), Disease (Feminine Health, Chronic Disease, Benign Prostatic Hyperplasia, Bladder Cancer, Mental Disorders), Age (Below 20 years, 20 to 39 years, 40 to 59 years, 60 to 79 years, 80+ years) – Industry Trends and Forecast to 2030.
Urinary Incontinence Care Products Market Analysis and Size
The major factors driving the growth of the urinary incontinence care products market include an ageing population with urinary and faecal incontinence issues, increased awareness of personal hygiene, a wide range of products for both men and women, the development of innovative products that provide better comfort and hygiene, the availability of products, and the introduction of innovative environmentally friendly products into the market. On the other hand, the increasing number of technological advancements, as well as the development of new products and the easy availability of the product online and over the counter, will create lucrative opportunities, resulting in the growth of the urinary incontinence care products market during the forecast period.
Data Bridge Market Research analyses that the urinary incontinence care products market which was USD 11.99 billion in 2022, is expected to reach USD 21.38 billion by 2030, at a CAGR of 7.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Urinary Incontinence Care Products Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product Type (Urine Bags, Urinary Catheter, Others), Sales Channel (Institutional Sales, Modern Trade, Departmental Stores, Convenience Stores, Specialty Stores, Online Retailers, Drug Stores, Other Sales Channels), Raw Material (Latex, Plastic, Cotton Fabrics, Super Absorbents), Consumer Orientation (Male, Female), Functionality (Disposable, Reusable), Product Claim (Organic, Natural), Application (Urine Incontinence, Faecal Incontinence, Dual Incontinence) Incontinence Type (Stress, Urge, Mixed), Disease (Feminine Health, Chronic Disease, Benign Prostatic Hyperplasia, Bladder Cancer, Mental Disorders), Age (Below 20 years, 20 to 39 years, 40 to 59 years, 60 to 79 years, 80+ years) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Torrent Pharmaceuticals Ltd. (India), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Alembic Pharmaceuticals Limited (India), Coloplast Group (Denmark), Boston Scientific Corporation (U.S.), Alembic Pharmaceuticals Limited (India), B. Braun SE (Germany), BD (U.S.), Baxter (U.S.), Johnson & Johnson Private Limited (U.S.), Medtronic (Ireland), AstraZeneca (U.K.), Merck & Co., Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Urinary incontinence is a medical condition that causes involuntary urine loss. Medical devices are used to help build and strengthen pelvic floor muscles and treat chronic urinary incontinence. Electrical muscle stimulation is one of these devices, and it aids in the effective, safe, and non-invasive treatment of stress, urge, and mixed urinary incontinence. Several manufacturers are currently working on purpose-built devices for the female population.
Urinary Incontinence Care Products Market Dynamics
Drivers
- Rise in the prevalence of urinary incontinence
The rising prevalence of urinary incontinence is a major driver of market expansion (UI). A urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, pregnancy, menopause, childbirth and post-radical prostatectomy surgery in men can all cause urinary incontinence symptoms. These are the certain factors which propel the market growth.
Opportunities
- Increasing investment for healthcare infrastructure
The significant factor influencing the growth rate of the urinary incontinence market is rising healthcare expenditure, which aids in infrastructure improvement.
Furthermore, rising public and private sector initiatives to raise awareness, as well as an increase in the number of cases of diabetes, neurological diseases, obesity will expand the urinary incontinence market. The increasing trend of non-invasive treatment options and high disposable income will expand the urinary incontinence market. Along with this, the growing geriatric population and rising incidences of chronic diseases will accelerate market growth. Consumption of sweeteners, caffeine, carbonated drinks, chocolates, muscle relaxants, sparkling water and artificial chilli peppers is expected to increase the risk of urinary incontinence and thus cushion the market's growth rate.
Restraints/Challenges
- High cost of treatment
The high cost of treatment and devices will slow the market's growth rate. In developing economies, a lack of healthcare infrastructure will pose a challenge to the urinary incontinence market. Furthermore, a lack of skilled professionals and the complications associated with the procedures will act as a restraint and further impede the market's growth rate during the forecast period of 2023-2030.
This urinary incontinence care products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinary incontinence care products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Urinary Incontinence Care Products Market
The COVID-19 virus has spread to nearly every country on the planet since its discovery in December 2019, prompting the World Health Organization (WHO) to declare it a public health emergency. Healthcare systems around the world have been severely disrupted in the coronavirus pandemic because of the financial crisis and the delay in specialty healthcare delivery while prioritising COVID-19-related treatments. Patients were unable to see their controls for a variety of reasons, including difficulty finding a doctor, concerns about infection transmission, and an inability to continue therapies and necessary procedures due to pandemic restrictions. In recent months, such considerations may have had a negative impact on the urinary incontinence care products market.
Recent Developments
- In 2020, Rigicon announced the release of two new artificial urinary sphincter models the ContiClassic Artificial Urinary Sphincter and the ContiReflex Artificial Urinary Sphincter. AUS stands for Artificial Urine Sphincter, which is a medical device used to treat urinary incontinence. When non-surgical and behavioural treatment approaches fail, a surgical treatment option is the Artificial Urinary Sphincter.
Global Urinary Incontinence Care Products Market Scope
The urinary incontinence care products market is segmented on the basis of product type, sales channel, raw material, consumer orientation, functionality, product claim, application, incontinence type, disease, and age. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Urine Bags
- Leg urine bags
- Bedside urine bags
- Urinary Catheter
- Foley catheter
- Intermittent catheter
- External catheter
- Others
Sales Channel
- Institutional Sales
- Hospitals
- Skilled nursing facilities
- Long term care centers
- Hospice/ palliative care
- Modern Trade
- Departmental Stores
- Convenience Stores
- Specialty Stores
- Online Retailers
- Drug Stores
- Other Sales Channels
Raw Material
- Latex
- Plastic
- Cotton Fabrics
- Super Absorbents
Consumer Orientation
- Male
- Female
Functionality
- Disposable
- Reusable
Product Claim
- Organic
- Natural
Application
- Urine Incontinence
- Faecal Incontinence
- Dual Incontinence
Incontinence Type
- Stress
- Urge
- Mixed
Disease
- Feminine Health
- Pregnancy and child birth
- Menopause
- Hysterectomy
- Chronic Disease
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Mental Disorders
Age
- Below 20 years
- 20 to 39 years
- 40 to 59 years
- 60 to 79 years
- 80+ years
Urinary Incontinence Care Products Market Regional Analysis/Insights
The urinary incontinence care products market is analyzed and market size insights and trends are provided by country, product type, sales channel, raw material, consumer orientation, functionality, product claim, application, incontinence type, disease, and age as referenced above.
The countries covered in the urinary incontinence care products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the urinary incontinence care products market because of the region's rapid adoption of newer techniques Furthermore, the increasing presence of major key players and well-established healthcare infrastructure will drive the market's growth rate in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the increasing number of generic manufacturers and government initiatives in this region Furthermore, the development of healthcare infrastructure will accelerate the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The urinary incontinence care products market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for urinary incontinence care products market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the urinary incontinence care products market. The data is available for historic period 2011-2021.
Competitive Landscape and Urinary Incontinence Care Products Market Share Analysis
The urinary incontinence care products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinary incontinence care products market.
Some of the major players operating in the urinary incontinence care products market are:
- Torrent Pharmaceuticals Ltd. (India)
- Apotex Inc.
- Eli Lilly and Company (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Alembic Pharmaceuticals Limited (India)
- Coloplast Group (Denmark)
- Boston Scientific Corporation (U.S.)
- Alembic Pharmaceuticals Limited (India)
- B. Braun SE (Germany)
- BD (U.S.)
- Baxter (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Medtronic (Ireland)
- AstraZeneca (U.K.)
- Merck & Co., Inc. (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.